Standout Papers

X-Tile 1994 2026 2004 2015 2004 2005 2021 1994 2019 500 1000 1.5k 2.0k 2.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. X-Tile
    2004 2.9k citations Robert L. Camp, Marisa Dolled‐Filhart et al. Clinical Cancer Research profile →
  2. Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma
    2005 1.1k citations Levi A. Garraway, Hans R. Widlund et al. Nature profile →
  3. PD-L1 as a biomarker of response to immune-checkpoint inhibitors
    2021 956 citations Deborah B. Doroshow, Sheena Bhalla et al. Nature Reviews Clinical Oncology profile →
  4. Adhesion between epithelial cells and T lymphocytes mediated by E-cadherin and the αEβ7 integrin
    1994 946 citations K L Cepek, Sunil K. Shaw et al. Nature profile →
  5. Artificial intelligence in digital pathology — new tools for diagnosis and precision oncology
    2019 916 citations Kaustav Bera, Kurt A. Schalper et al. Nature Reviews Clinical Oncology profile →
  6. Estrogen and Progesterone Receptor Testing in Breast Cancer: ASCO/CAP Guideline Update
    2020 838 citations Kimberly H. Allison, M. Elizabeth H. Hammond et al. Journal of Clinical Oncology profile →
  7. Quantitative Assessment of the Heterogeneity of PD-L1 Expression in Non–Small-Cell Lung Cancer
    2015 676 citations Joseph McLaughlin, Gang Han et al. JAMA Oncology profile →
  8. Validation of Tissue Microarray Technology in Breast Carcinoma
    2000 653 citations Robert L. Camp, Lori A. Charette et al. Laboratory Investigation profile →
  9. Programmed death ligand-1 expression in non-small cell lung cancer
    2013 648 citations Vamsidhar Velcheti, Kurt A. Schalper et al. Laboratory Investigation profile →
  10. Automated subcellular localization and quantification of protein expression in tissue microarrays
    2002 645 citations Robert L. Camp, Gina G. Chung et al. Nature Medicine profile →
  11. Alpha 1(E)-catenin is an actin-binding and -bundling protein mediating the attachment of F-actin to the membrane adhesion complex.
    1995 627 citations David L. Rimm, Partow Kebriaei et al. Proceedings of the National Academy of Sciences profile →
  12. Molecular Classification Identifies a Subset of Human Papillomavirus–Associated Oropharyngeal Cancers With Favorable Prognosis
    2006 618 citations Paul Weinberger, Ziwei Yu et al. Journal of Clinical Oncology profile →
  13. A Prospective, Multi-institutional, Pathologist-Based Assessment of 4 Immunohistochemistry Assays for PD-L1 Expression in Non–Small Cell Lung Cancer
    2017 574 citations David L. Rimm, Gang Han et al. JAMA Oncology profile →
  14. Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy
    2019 483 citations Jun Wang, Jingwei Sun et al. Nature Medicine profile →
  15. Immunotherapy in Non–Small Cell Lung Cancer: Facts and Hopes
    2019 464 citations Deborah B. Doroshow, Miguel F. Sanmamed et al. Clinical Cancer Research profile →
  16. Comparison of Biomarker Modalities for Predicting Response to PD-1/PD-L1 Checkpoint Blockade
    2019 401 citations Steve Lu, Julie E. Stein et al. JAMA Oncology profile →
  17. In Situ Tumor PD-L1 mRNA Expression Is Associated with Increased TILs and Better Outcome in Breast Carcinomas
    2014 366 citations Kurt A. Schalper, Vamsidhar Velcheti et al. Clinical Cancer Research profile →
  18. A proposal for validation of antibodies
    2016 353 citations Mathias Uhlén, Anita Bandrowski et al. Nature Methods profile →
  19. PD-L1 Expression in Lung Cancer
    2016 335 citations Hui Yu, Theresa A. Boyle et al. Journal of Thoracic Oncology profile →
  20. Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach
    2025 20 citations María Villalba, Miguel F. Sanmamed et al. Nature Reviews Clinical Oncology profile →

Immediate Impact

5 by Nobel laureates 25 from Science/Nature 76 hit
Sub-graph 1 of 18

Citing Papers

The β1-adrenergic receptor links sympathetic nerves to T cell exhaustion
2023 HitNature
Early detection of cancer
2022 HitScience
2 intermediate papers

Works of David L. Rimm being referenced

Artificial intelligence in digital pathology — new tools for diagnosis and precision oncology
2019 Hit
Early and multiple origins of metastatic lineages within primary tumors
2016
and 2 more

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David L. Rimm 19.7k 17.9k 8.2k 7.9k 7.0k 545 41.1k
Isaiah J. Fidler 21.3k 1.1× 21.9k 1.2× 13.6k 1.7× 8.1k 1.0× 8.7k 1.3× 504 48.4k
Kenneth J. Pienta 17.9k 0.9× 21.8k 1.2× 12.1k 1.5× 17.5k 2.2× 7.1k 1.0× 672 49.6k
Ralph R. Weichselbaum 18.6k 0.9× 17.9k 1.0× 7.6k 0.9× 10.6k 1.3× 9.4k 1.3× 706 48.2k
Robert S. Kerbel 16.5k 0.8× 24.5k 1.4× 13.4k 1.6× 5.8k 0.7× 5.5k 0.8× 401 41.7k
Takashi Takahashi 11.3k 0.6× 19.7k 1.1× 9.0k 1.1× 6.4k 0.8× 6.1k 0.9× 700 37.1k
Robert C. Bast 13.7k 0.7× 17.8k 1.0× 9.6k 1.2× 3.5k 0.4× 6.9k 1.0× 609 44.8k
Roger E. McLendon 12.9k 0.7× 19.4k 1.1× 11.8k 1.4× 5.3k 0.7× 5.3k 0.8× 330 41.9k
Darell D. Bigner 15.6k 0.8× 22.0k 1.2× 10.4k 1.3× 6.5k 0.8× 8.3k 1.2× 623 48.1k
Ignacio I. Wistuba 16.3k 0.8× 16.7k 0.9× 9.0k 1.1× 12.3k 1.6× 4.2k 0.6× 685 35.7k
Guido Sauter 13.6k 0.7× 17.6k 1.0× 8.1k 1.0× 10.0k 1.3× 2.7k 0.4× 600 34.9k

All Works

Loading papers...

Rankless by CCL
2026